Preinvasive  ||| S:0 E:12 ||| FW
lesions  ||| S:12 E:20 ||| FW
in  ||| S:20 E:23 ||| FW
gynaecology -   ||| S:23 E:38 ||| FW
vagina  ||| S:38 E:45 ||| FW
Preinvasive  ||| S:45 E:57 ||| FW
lesions  ||| S:57 E:65 ||| FW
of  ||| S:65 E:68 ||| IN
the  ||| S:68 E:72 ||| DT
vagina  ||| S:72 E:79 ||| NNS
are  ||| S:79 E:83 ||| VBP
relatively  ||| S:83 E:94 ||| RB
rare ||| S:94 E:98 ||| JJ
,  ||| S:98 E:100 ||| ,
clearly  ||| S:100 E:108 ||| RB
defined  ||| S:108 E:116 ||| VBN
afflictions ||| S:116 E:127 ||| NN
,  ||| S:127 E:129 ||| ,
originating  ||| S:129 E:141 ||| VBG
most  ||| S:141 E:146 ||| JJS
of  ||| S:146 E:149 ||| IN
all  ||| S:149 E:153 ||| DT
in  ||| S:153 E:156 ||| IN
association  ||| S:156 E:168 ||| NN
with  ||| S:168 E:173 ||| IN
the  ||| S:173 E:177 ||| DT
highrisk  ||| S:177 E:186 ||| JJ
human  ||| S:186 E:192 ||| JJ
papillomavirus  ||| S:192 E:207 ||| JJ
infection  ||| S:207 E:217 ||| NN
( ||| S:217 E:218 ||| -LRB-
HR  ||| S:218 E:221 ||| NNP
HPV ||| S:221 E:224 ||| NNP
) ||| S:224 E:225 ||| -RRB-
.  ||| S:225 E:227 ||| .
The  ||| S:227 E:231 ||| DT
most  ||| S:231 E:236 ||| RBS
frequent  ||| S:236 E:245 ||| JJ
appearance  ||| S:245 E:256 ||| NN
is  ||| S:256 E:259 ||| VBZ
in  ||| S:259 E:262 ||| IN
coincidence  ||| S:262 E:274 ||| NN
with  ||| S:274 E:279 ||| IN
preinvasive  ||| S:279 E:291 ||| JJ
lesions  ||| S:291 E:299 ||| NNS
of  ||| S:299 E:302 ||| IN
uterine  ||| S:302 E:310 ||| JJ
cervix  ||| S:310 E:317 ||| NN
and  ||| S:317 E:321 ||| CC
in  ||| S:321 E:324 ||| IN
vaginal  ||| S:324 E:332 ||| JJ
cuff  ||| S:332 E:337 ||| NN
after  ||| S:337 E:343 ||| IN
hysterectomy ||| S:343 E:355 ||| NN
.  ||| S:355 E:357 ||| .
Preinvasive  ||| S:357 E:369 ||| JJ
vaginal  ||| S:369 E:377 ||| JJ
lesions  ||| S:377 E:385 ||| NNS
are  ||| S:385 E:389 ||| VBP
divided  ||| S:389 E:397 ||| VBN
into  ||| S:397 E:402 ||| IN
squamous  ||| S:402 E:411 ||| JJ
lesions  ||| S:411 E:419 ||| NNS
( ||| S:419 E:420 ||| -LRB-
vaginal  ||| S:420 E:428 ||| FW
intraepithelial  ||| S:428 E:444 ||| FW
neoplasia ||| S:444 E:453 ||| FW
)  ||| S:453 E:455 ||| -RRB-
and  ||| S:455 E:459 ||| CC
nonsquamous  ||| S:459 E:471 ||| JJ
lesions ||| S:471 E:478 ||| NNS
.  ||| S:478 E:480 ||| .
Vaginal  ||| S:480 E:488 ||| JJ
adenosis  ||| S:488 E:497 ||| NN
belongs  ||| S:497 E:505 ||| VBZ
to  ||| S:505 E:508 ||| TO
nonsquamous  ||| S:508 E:520 ||| VB
vaginal  ||| S:520 E:528 ||| JJ
preinvasive  ||| S:528 E:540 ||| JJ
lesions  ||| S:540 E:548 ||| NNS
and  ||| S:548 E:552 ||| CC
is  ||| S:552 E:555 ||| VBZ
a  ||| S:555 E:557 ||| DT
precursor  ||| S:557 E:567 ||| JJ
lesion  ||| S:567 E:574 ||| NN
of  ||| S:574 E:577 ||| IN
vaginal  ||| S:577 E:585 ||| CD
clear  ||| S:585 E:591 ||| CD
cell  ||| S:591 E:596 ||| NN
carcinoma ||| S:596 E:605 ||| NN
.  ||| S:605 E:607 ||| .
Surgical  ||| S:607 E:616 ||| NNP
and  ||| S:616 E:620 ||| CC
nonsurgical  ||| S:620 E:632 ||| JJ
techniques  ||| S:632 E:643 ||| NNS
including  ||| S:643 E:653 ||| VBG
laser  ||| S:653 E:659 ||| NN
destructive  ||| S:659 E:671 ||| JJ
methods  ||| S:671 E:679 ||| NNS
and  ||| S:679 E:683 ||| CC
local  ||| S:683 E:689 ||| JJ
administration  ||| S:689 E:704 ||| NN
of  ||| S:704 E:707 ||| IN
5-  ||| S:707 E:710 ||| CD
fluorouracile  ||| S:710 E:724 ||| NNS
are  ||| S:724 E:728 ||| VBP
used  ||| S:728 E:733 ||| VBN
in  ||| S:733 E:736 ||| IN
the  ||| S:736 E:740 ||| DT
treatment  ||| S:740 E:750 ||| NN
of  ||| S:750 E:753 ||| IN
preinvasive  ||| S:753 E:765 ||| JJ
lesions  ||| S:765 E:773 ||| NNS
of  ||| S:773 E:776 ||| IN
vagina ||| S:776 E:782 ||| NN
.  ||| S:782 E:784 ||| .
